Background {#Sec1}
==========

Children and adolescents infected with HIV/AIDS (CA-HIV) are at increased risk of developmental and neuropsychological disturbances owing to both the direct and indirect effects of the HIV virus \[[@CR1], [@CR2]\]. HIV has direct neurotoxic effects on brain structures involved in the regulation of emotion, behavior, and cognition, this effect is thought to result primarily from HIV's ability to induce inflammatory factors that cause neuronal cell damage and eventual cell death \[[@CR1]\]. The indirect effects of HIV include social stressors, poverty, illness and trauma on morbidity and mortality \[[@CR1], [@CR2]\]. Previous research suggests that HIV-1 mutations differ by subtype, which may lead to increased resistance to anti-retroviral therapy (ART) thus resulting in persistence of neurological and neurodevelopmental disorders among CA-HIV receiving ART \[[@CR2]\].

In sub Saharan Africa, with the exception of epilepsy, few studies have attempted to determine the prevalence of neurologic disease among children and adolescents and therefore characterize their clinical correlates \[[@CR1]\]. In one study conducted in East Africa, approximately two-thirds of new patients presenting to a child and adolescent psychiatry service had epilepsy \[[@CR3]\], and seizures are also common among individuals with HIV/AIDS \[[@CR4]\]. Although neurological disorders are reported to be associated with HIV/AIDS \[[@CR1], [@CR2], [@CR5]\], no such studies have been conducted among CA-HIV in Uganda. The primary objectives of the present study were to (a) document the prevalence of neurological disorders among a large sample of CA-HIV attending rural and urban HIV clinics in Uganda, (b) characterize the relation of neurological disorders with a wide range of commonly studied clinical correlates, (c) establish the co-occurrence of neurological and psychiatric disorders, and (d) investigate the relation of neurological disorders with important indices of functioning.

Methods {#Sec2}
=======

Participants {#Sec3}
------------

The study sample comprises 1070 CA-HIV and their caregivers who were evaluated at their 6-month follow-up visit as part of their participation in the *Mental health among HIV infected CHildren and Adolescents in KAmpala and Masaka, Uganda (CHAKA) study.* Details about the study design, eligibility criteria and study procedures of CHAKA are described in a previous publication \[[@CR6]\]. Of the initial 1339 CA-HIV/ caregiver dyads interviewed at baseline, 269 (20.0%) were not included in the 6 months analyses for various reasons including: 3 had incomplete records and the remaining 266 CA-HIV did not turn up for the 6 months follow-up interview despite various attempts to reach them. Some of these later returned for their 12-month interview reporting that they had temporarily transferred out of the study clinic.

Measures {#Sec4}
--------

The assessment battery comprised locally adapted standardised psychosocial instruments described in earlier publications \[[@CR6], [@CR7]\] that have previously been used in the USA \[[@CR8]--[@CR10]\]. Study variables reported in this paper are described in Additional file [1](#MOESM1){ref-type="media"} and are arranged according to the conceptual framework depicted in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Conceptual framework for clinical correlates of neurological disorders

### Epilepsy {#Sec5}

Probable clinical epilepsy was based on a score of *yes* to the following item: *Has this child/adolescent ever suffered repeated seizures or convulsions without fever being present?*

### Tic and elimination disorders {#Sec6}

Motor tics and vocal tics and elimination disorders (enuresis and encopresis) were established using a clinically practical, DSM-5-referenced, behaviour rating scale, the Child and Adolescent Symptom Inventory-5 (CASI-5) \[[@CR10]\], which was previously used to study emotional and behavioral disorders among CA-HIV in the United States \[[@CR9], [@CR11]\]. The items in the CASI-5 are based on symptom statements that appear in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Informants indicate whether these symptoms occur, *never*, *sometimes*, *often*, or *very often*. CASI-5 items can be scored in several different ways, and in the present study we used the symptom count cut-off score for these items. Symptom count cut-off score indicates whether child/adolescent has the prerequisite number of symptoms necessary for a DSM-5 diagnosis, which for this study was a rating of *often* or *very often*.

Psychiatric disorders {#Sec7}
---------------------

The CASI-5 also provides scoring algorithms for estimating psychiatric diagnoses. For purposes of this paper, we generated clinical cutoff scores for 12 psychiatric disorders, which we categorised as either internalising or externalising. The internalising disorder category included generalised anxiety disorder, social anxiety disorder, separation anxiety disorder, specific phobia disorder, panic disorder, post-traumatic stress disorder (PTSD), major depressive episode (MDD and dysthymia). Externalising disorders included attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder, and callous unemotional. To receive a clinical cutoff score, a CA-HIV had to meet both DSM-based symptom count criteria for a specific disorder as well as impairment cutoff criteria. The latter is a rating of *often* or *very often* to the question of whether symptoms interceded with social, academic, or chore-related functioning. The CASI-5 was administered by trained psychiatric nurse research assistants.

### Sexual intercourse {#Sec8}

Sexual intercourse was a response of *yes* to the question, *Have you ever had sex?* Possible responses were yes/no*,* this question was asked only to adolescents.

Statistical analysis {#Sec9}
--------------------

Prevalence estimates and 95% confidence intervals for the three neurological outcomes of enuresis/encopresis, motor or vocal tics and probable epilepsy are reported overall and by age and gender category. Using a conceptual framework (Fig. [1](#Fig1){ref-type="fig"}) based on both HIV- and non-HIV-related factors hypothesized to be associated with neurological disorders, we investigated several widely studied variables. Associations between each of the neurological disorders evaluated at the 6-month follow-up period, baseline socio-demographic and HIV-related factors were undertaken using logistic regression models. Multivariable models were selected based on backward elimination, and models were fitted sequentially to include significant factors from each category at *p* \< 0.1. The final model included the pre-defined design variable of study site, age and sex and all significant factors from the previous models.

The prevalence and 95% confidence intervals of comorbidities between neurological disorders as well as externalising and internalising disorders were estimated. We investigated associations of neurological disorders with the following outcomes using logistic regression: social outcomes as evidenced by disciplinary actions in school, any missed days at school during the last term, and onset of sexual intercourse (yes/no; adolescents only); and health-related outcomes such as any visit to the health unit in the last month; any hospital admissions in the last 6 months, and non-adherence to ART defined as any missed ART in the last 3 days (yes/no). For each outcome, associations were assessed using logistic regression models, adjusted for age, sex, study site and ethnicity. In accordance with previously published work from the CHAKA study, adjustment was made for CD4 cell count, visits to the health unit, and hospital admissions and for HIV ART status for the adherence outcome. Similarly, we used 5% *p*-values for these descriptive exploratory analyses because it is not clear how many comparisons should be corrected for and precautions taken in interpretation due to multiple comparisons. We used Bonferroni correction adjusted *p*-values by multiplying the observed *p* value from the significance tests by the number of tests k, for each of the analyses with psychiatric symptom outcomes \[[@CR26], [@CR27]\]. Then if any kP is less than 0.05 the differences in the two groups (with versus those without neurological disorders) are significant at the 0.05 level.

Results {#Sec10}
=======

Characteristics of study participants {#Sec11}
-------------------------------------

Overall, the study included 677 (63.3%) children aged 5--11 years and 393 (36.7%) adolescents aged 12--17 years. The urban and rural study sites contributed equally. There were slightly more females (52%) than males (48%). With regard to HIV illness parameters, 88% had CD4 counts equal or greater than 350 cells/μL, and most (95%) of the participants were receiving ART (Additional File [2](#MOESM2){ref-type="media"}).

Prevalence of neurological disorders {#Sec12}
------------------------------------

One hundred ninety eight participants had at least one neurological disorder (prevalence 18.5%). The prevalence of neurological disorders was 10% for enuresis/encopresis, 5.3% for motor/vocal tics, and 4% for probable epilepsy (Table [1](#Tab1){ref-type="table"}). Of the 198 with any neurological disorder, 189 (17.7%) had at most one disorder \[tics (*n* = 51, enuresis/encopresis (*n* = 102), and epilepsy (*n* = 36)\], and 9 (0.8%) had at most two disorders \[tics and enuresis/encopresis (*n* = 2), tics and epilepsy (*n* = 4), enuresis/encopresis and epilepsy (*n* = 3)\]. The prevalence of any neurological disorder was 18% in males and 19% in females. The prevalence of probable epilepsy among children and adolescent was similar (4.0% vs. 4.1%), and enuresis/encopresis was higher among children than adolescents (14.0% vs. 3.1%), whereas motor/vocal tics were more frequent among adolescents than children (11% vs. 2%). Marginal gender differences in prevalence of probable epilepsy in females versus males (5% vs 3%) and in enuresis/encopresis in females versus males (9% vs 11%), whereas motor/vocal tics were more common in females versus males (7% vs 4%).Table 1Prevalence and 95% CI of neurological disorders based on symptom counts cut-off scores of the CASI-5SubgroupNPrevalence enuresis/encopresis n (%) 95% CIPrevalence motor/vocal ticsPrevalence epilepsyPrevalence any neurological disorderChildren67795 (14.0%) (11.4, 16.7)14 (2.1%) (1.0, 3.1)27 (4.0%) (2.5, 5.5)131 (19.4%) (16.4, 22.3)Adolescents39312 (3.1%) (1.3, 4.8)43 (10.9%) (7.8, 14.0)16 (4.1%) (2.1, 6.0)67 (17.1%) (13.3, 20.8)Female55048 (8.7%) (6.4, 11.1)37 (6.7%) (4.6, 8.8)26 (4.7%) (3.0, 6.5)106 (19.3%) (16.0, 22.6)Male52059 (11.3%) (8.6, 14.1)20 (3.9%) (2.2, 5.5)17 (3.3%) (1.7, 4.8)92 (17.7%) (14.4, 21.0)Overall1070107 (10%) (8.1, 11.8)57 (5.3%) (4.0, 6.7)43 (4.0%) (2.8, 5.2)198 (18.5%) (16.2, 20.8)

Correlates of elimination disorders {#Sec13}
-----------------------------------

Factors associated with enuresis/encopresis symptom count cut-off scores in the multivariable model were younger age (aOR 0.79, 95% CI 0.73--0.85, *P \< 0.001*), ethnicity (being a non-Muganda with aOR of 0.56, CI 0.33--0.95, *P = 0.03*), living in rural areas (aOR 2.25, CI 1.42--3.54, *P = 0.4*), and less viral load suppression at baseline (aOR 1.75, CI 1.08--2.83, *P = 0.02*) (Additional file [3](#MOESM3){ref-type="media"}).

Clinical correlates of motor and vocal tics) {#Sec14}
--------------------------------------------

CA-HIV socio-demographic variables associated with motor/vocal tics symptom count cut off scores in the multivariable model were increasing age (aOR 1.28, CI 1.17--1.40, *P \< 0.001*) and ethnicity (being non-Muganda; aOR 0.33, CI 0.14--0.76, *P = 0.01)* adjusted for site and sex (Additional file [3](#MOESM3){ref-type="media"}).

Clinical correlates of probable epilepsy {#Sec15}
----------------------------------------

We found ethnicity marginally associated with probable epilepsy (being a non-Muganda with aOR of 1.87, CI 0.98--3.57, *P = 0.06*), adjusted for age, sex and site. None of the other factors was associated with probable epilepsy (*p \> 0.1*) (Additional file [3](#MOESM3){ref-type="media"}).

Association with psychiatric symptoms {#Sec16}
-------------------------------------

CA-HIV with enuresis/encopresis had a higher risk for co-occurring externalising disorder (18.7%) and internalising disorder (36.4%) (*p \< 0.001*, and *p* \< 0.001, respectively) (Table [2](#Tab2){ref-type="table"}). All the other associations between neurological disorders and psychiatric comorbidities were not significant.Table 2Comorbidities between neurological disorders with externalising and internalising psychiatric disorders*N* = 1070Enuresis/ Encopresis n(%) CI, *p*-valueMotor/vocal ticsEpilepsyAny neurological disordern1075743198Externalising disorder20 (18.7%)5 (8.8%)4 (9.3%)28 (14.1)(12.4, 27.3)(3.6, 19.5)(3.6, 19.5)(9.9, 19.7)***P*** **\< 0.001*P*** **= 0.9*P*** **= 0.9*P*** **= 0.01**Internalising disorder39 (36.4%)14 (24.6%)14 (32.6%)63 (31.8%)(27.8, 46.0)(15.0, 37.4)(20.1, 25.2)(25.7, 38.7)***P*** **\< 0.001*P*** **= 0.8*P*** **= 0.1*P*** **= 0.001**Externalising includes; any ADHD, ODD, CD, callous unemotional by symptom frequency, or clinically significant or interferes with functionInternalising; MDD, persistent dysthymia, GAD, panic disorder, specific phobia, PTSD, any social anxiety, separation anxiety,

Association with social and academic functioning {#Sec17}
------------------------------------------------

Having *any* neurological disorder was associated with an earlier onset of sexual intercourse (adjusted OR 4.06, 95% CI 1.26--13.1, *P = 0.02*). The relation of neurological disorders with the other social or academic outcomes were not significant (Table [3](#Tab3){ref-type="table"}).Table 3Association between neurological disorders and adverse outcomesOutcomesEnuresis/ Encopresis aOR, *p*-value^a^Motor/ Vocal TICS aOR, *p*-value^a^Epilepsy aOR, *p*-value^a^Any neurological disorder aOR, *p*-value^a^Any poor social functioning (Suffered disciplinary measures ie suspension, dismissal)^f^0.73 (0.16, 3.27)0.71 (0.23, 2.15)1.10 (0.43, 2.77)1.06 (0.31, 3.61)***P = 0.7**P = 0.5**P = 0.8**P = 0.9***Any days missed at school in the last term^f^0.89 (0.59, 1.35)0.93 (0.67, 1.30)1.35 (0.99, 1.85)1.17 (0.78, 1.74)***P = 0.6**P = 0.7**P = 0.06**P = 0.4***Any visit to the health unit in the last month^c,f^O.44 (0.17, 1.13)0.57 (0.30, 1.06)0.98 (0.59, 1.63)1.39 (0.76, 2.56)***P = 0.09**P = 0.08**P = 0.9**P = 0.3***Any admission to hospital in last 6 months^c,6^0.66 (0.15, 2.91)0.94(0.34, 2.60)0.85 (0.34, 2.13)1.29 (0.44, 3.79)***P = 0.6**P = 0.9**P = 0.7**P = 0.6***Early onset of sexual intercourse^b,e,f^N/A0.78 (0.26, 2.30)1.87 (0.56, 6.21)4.06 (1.26, 13.1)***P = 0.7**P = 0.3**P = 0.02***Any non-adherence to ART in last 3 days^b,d,f^N/A0.78 (0.33, 1.85)1.21 (0.46, 3.21)1.60 (0.55, 4.66)***P = 0.6**P = 0.7**P = 0.4***^a^Adjusted for age, sex, study site and ethnicity^b^only asked in adolescents,^c^Adjusted for CD4 cell count at baseline^d^Non adherence to ART adjusted for CD4 count at baseline and whether CA-HIV on ARTN/A -- outcome does not vary^e^Bonferroni adjusted *p* value is 0.02\*3 = 0.06^f^Bonferroni adjusted p value is \> 0.1

Discussion {#Sec18}
==========

This study aimed to determine the prevalence of neurological disorders among CA-HIV in Uganda and their association with commonly studied mental health clinical correlates, associated psychiatric comorbidities, and functioning. The prevalence of at least one neurological disorder among CA-HIV was 18.5%, which is consistent with findings from previous studies that suggest a high prevalence of neurological disorders among CA-HIV \[[@CR2], [@CR4]\].

The prevalence of probable epilepsy in this study was 4%, which is within the range reported in prior studies both in the West and in South Africa. Kellinghaus and colleagues (2008) found that among HIV positive adult patients attending a neurological clinic in Germany, 6.1% had epilepsy \[[@CR12]\]. Pascual-Sedano and colleagues (1999) reported a 3% prevalence for new-onset seizures during a one year follow-up period among an adult HIV cohort in Spain \[[@CR13]\]. In one of the few studies in this area from sub-Saharan Africa, Samai and colleagues (2013) noted that among HIV positive youth in South Africa, 7.6% had epilepsy \[[@CR14]\].

The prevalence of enuresis/encopresis in this study was 10%, and we were unable to locate any other studies in the extant literature about these problems among CA-HIV for purposes of comparison. A rate of enuresis of 5--9% \[[@CR15]--[@CR17]\] and that of encopresis of 1--3% \[[@CR15]--[@CR17]\] have been reported among general population samples of children. In this study, the prevalence for motor/vocal tics was 5.3%, a figure within the 4--12% range reported among children in the general population \[[@CR18]\].

In this study, the only variable that was marginally associated with probable epilepsy was ethnicity. Belonging to an ethnic group that was not indigenous to the study area conferred an increased risk for epilepsy. Ethnicity could be associated with epilepsy for two reasons. Firstly, ethnicity may be a pointer to the genetic underpinnings of epilepsy \[[@CR19]\]. Secondly, ethnicity may be a marker for socio-economic disadvantage with respondents who were not indigenous to the study area being more likely to experience medical complications while growing up that are associated with both social disadvantage and epilepsy such as birth trauma, other central nervous system infections (including complicated malaria), and traumatic brain injury \[[@CR20]\].

In this study, enuresis/encopresis were significantly associated with younger age and marginally higher among males than in females. Both enuresis and encopresis have previously been reported to decrease with increasing age \[[@CR16], [@CR21], [@CR22]\] and to be higher among males than among females \[[@CR21], [@CR22]\]. In this study, enuresis/encopresis was significantly associated with living in a rural area. Living in a rural area was probably an index of low socio-economic status. Indeed, in a Turkish study \[[@CR16]\], enuresis was reported to be associated with low maternal education and with low monthly income, indices of poor socio-economic status. Ethnicity was significantly associated with enuresis/encopresis in this study. As previously discussed under probable epilepsy, the association between enuresis/encopresis and ethnicity may be underlined by the same reasons namely, as a pointer to an underlying genetic underpinning for enuresis/encopresis \[[@CR23]\], secondly, as a marker for socio-economic disadvantage. The association between enuresis/encopresis and 'less HIV viral load suppression' observed in this study may be due to the direct neurotoxic effect of HIV or/ and to the increased psychological distress associated with a worse HIV clinical state. Lastly, enuresis/encopresis were the only neurological disorders significantly associated with both externalising and internalising psychiatric disorders. Previous research has reported that 20--40% of all children with enuresis have additional comorbid psychiatric disorders which include the externalising disorders of attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) and the internalising disorder of depression \[[@CR21]\]. In a large community study, children with encopresis were reported to have increased rates of the externalising disorders of ADHD and ODD and the internalising disorders of separation anxiety, specific phobia and generalised anxiety disorders \[[@CR24]\].

In this study motor/vocal tics were more common in females than in males. Scahill and colleagues (2014) in a review involving eleven community studies reported great variation in the female to male ratio of motor/vocal tics ranging from 1 to 1, 1 to 4, through to 1 to 10 \[[@CR25]\]. The factors significantly associated with motor/ vocal tics in this study included increasing age and ethnicity. Metzger and colleagues (2012) observed that as children progress into young adulthood, tics often go into remission \[[@CR18]\]. The significant association between motor/vocal tics and ethnicity as discussed under probable epilepsy is probably underlined by two factors, a genetic underpinning \[[@CR26]\] and social disadvantage.

Having any neurological disorder in this study was associated with an earlier onset of sexual intercourse. The reasons for this association were not immediately clear, however this relationship could be mediated through psychiatric comorbidity \[[@CR6]\].

This study has several strengths that include a large sample size, comprehensive assessment battery, and cross-cultural orientation, however, there were also several limitations. Firstly, it is not possible to comment on the casual direction of obtained associations given the cross-sectional design. Secondly, neurological disorders were assessed using single-item questions which increased the risk of false positives. Thirdly, because we did not have a comparable sample of sero-negative youth from the same geographic areas, it is not possible to know whether relations between neurological and putative mental health factors and functional outcomes are influenced by HIV status. This does not, however, detract from the clinical implications of our findings for CA-HIV. Lastly, by design, the present study focused on CA-HIV living in Uganda, and owing to considerable cultural variation in East Africa, our results may not be generalizable to other countries in the region.

Conclusions {#Sec19}
===========

In summary, approximately 18% of CA-HIV living in Uganda met DSM-5 symptom count plus impairment criteria for neurological disorder. Risk factors of neurological disorders among CA-HIV as hypothesised in the conceptual framework fell under two broad domains of HIV related factors (less viral load suppression at baseline) and socio-demographic factors (age, gender, ethnicity and residence in the rural area). However, the association between neurological disorders on one hand and ethnicity and externalising disorders on the other seem to suggest a genetic vulnerability component. The association between 'having a neurological disorder' and earlier age of sexual intercourse, may have important implications for clinical management, quality of life, long-term outcome and possible disease transmission. Moving forward, there is a definite need to integrate neurological/mental health services into routine HIV care for youth in low-and middle-income settings such as those in sub-Saharan Africa. This should include the development of cost effective assessment and treatment strategies that have high probability of success in challenging interventional settings.
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